Myovant Sciences Ltd. (MYOV) financial statements (2021 and earlier)

Company profile

Business Address SUITE 1, 3RD FLOOR
LONDON, SW1Y 4LB
State of Incorp. CA
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments74680156109181
Cash and cash equivalents71477156109181
Short-term investments323   
Other undisclosed cash, cash equivalents, and short-term investments(0)    
Restricted cash and investments  1  
Receivables  110
Other undisclosed current assets88953
Total current assets:75488167115184
Noncurrent Assets
Operating lease, right-of-use asset1011
Property, plant and equipment32211
Other noncurrent assets7443 
Other undisclosed noncurrent assets    0
Total noncurrent assets:2018641
TOTAL ASSETS:774106173119185
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5744113515
Accounts payable1215 53
Accrued liabilities4429543012
Interest and dividends payable  10 
Other undisclosed accounts payable and accrued liabilities  (44)  
Deferred revenue10140
Debt 26  
Due to related parties1 023
Other undisclosed current liabilities94055  
Total current liabilities:25286723718
Noncurrent Liabilities
Long-term debt and lease obligation101193  
Long-term debt, excluding current maturities  93  
Operating lease, liability1011
Liabilities, other than long-term debt737117100
Deferred revenue and credits00
Deferred revenue418 
Deferred rent credit  1
Due to related parties314114   
Other liabilities54   
Derivative instruments and hedges, liabilities    0
Other undisclosed noncurrent liabilities46 244 
Total noncurrent liabilities:79312897440
Total liabilities:1,0452141698119
Stockholders' equity
Stockholders' equity attributable to parent(271)(108)438167
Common stock00000
Common stock, share subscribed but unissued, subscriptions receivable    (0)
Additional paid in capital711684506266252
Accumulated other comprehensive income (loss)(17)(2)100
Accumulated deficit(965)(791)(502)(228)(85)
Total stockholders' equity:(271)(108)438167
TOTAL LIABILITIES AND EQUITY:774106173119185

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Gross profit:35    
Operating expenses(300)(275)(265)(141)(56)
Other undisclosed operating income (loss)5 (8)(2)(28)
Operating loss:(260)(275)(273)(143)(84)
Nonoperating income (expense)214 (0)0
Investment income, nonoperating03   
Foreign currency transaction gain (loss), before tax   (0)0
Other nonoperating income162   
Interest and debt expense(20)(18)(9)(2) 
Loss from continuing operations before equity method investments, income taxes:(259)(288)(282)(145)(83)
Other undisclosed income (loss) from continuing operations before income taxes  92(0)
Loss from continuing operations before income taxes:(259)(288)(273)(143)(84)
Income tax expense (benefit)0(1)(0)(0)0
Net loss:(259)(289)(274)(143)(83)
Other undisclosed net loss attributable to parent(5)    
Net loss available to common stockholders, diluted:(264)(289)(274)(143)(83)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Net loss:(259)(289)(274)(143)(83)
Other comprehensive loss(16)    
Comprehensive loss:(275)(289)(274)(143)(83)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(7)(2)0(0)0
Comprehensive loss, net of tax, attributable to parent:(282)(291)(273)(143)(83)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: